Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Zambon claims (S)-ibuprofen composition

May 3, 1996

Droxidopa studied in patients with chronic pain

May 3, 1996

MM-218 selected for development in emesis, diarrhea

April 26, 1996

Promising clinical results reported for CRF

April 26, 1996

NMDA/glycine-site antagonists revealed by RPR

April 26, 1996

Lilly claims mGluR antagonists for neurodegeneration

April 26, 1996

OPC-14523 improves learning in preclinical models

April 26, 1996

Mediolanum synthesizes AChE inhibitors for Alzheimer's

April 26, 1996

Scopolamine gel available in U.S. for motion sickness

April 26, 1996

Avonex approval imminent

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 12, 2025.
Could restricting diversity efforts stall women’s health research?
BioWorld
Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash against diversity, equity and...
Alkermes’ alixorexton hits endpoints in narcolepsy phase II
BioWorld
Alkermes plc’s placebo-controlled phase II study of alixorexton in treating narcolepsy type 2 (NT2) hit its dual primary endpoints, producing statistically...
Pazdur ‘optimal fit’ to lead FDA’s CDER
BioWorld
In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to...